A pilot clinical laboratory trial of paclitaxel and endobronchial brachytherapy in patients with non-small cell lung cancer

被引：0
|
作者：
Lee, JS
Komaki, R
Morice, RC
Ro, JY
Kalapurakal, SK
Schea, R
Murphy, WK
Shin, DM
Fox, NT
Walsh, GL
Hittelman, WN
Hong, WK
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Med Specialists, Houston, TX 77030 USA
[4] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[5] Univ Texas, MD Anderson Canc Ctr, Dept Thorac Surg, Houston, TX 77030 USA
[6] Univ Texas, MD Anderson Canc Ctr, Dept Clin Invest, Houston, TX 77030 USA
来源：
SEMINARS IN RADIATION ONCOLOGY | 1999年 / 9卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：121 / 129
页数：9
相关论文
共 50 条
  • [1] Palliative endobronchial brachytherapy for non-small cell lung cancer
    Reveiz, Ludovic
    Rueda, Jose-Ramon
    Felipe Cardona, Andres
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (12):
  • [2] Palliative endobronchial brachytherapy for non-small cell lung cancer
    Cardona, A. F.
    Reveiz, L.
    Ospina, E. G.
    Ospina, V
    Yepes, A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02):
  • [3] Endobronchial brachytherapy as definitive treatment for endobronchial metastasis after surgery of non-small cell lung cancer
    Atsushi Ito
    Daisuke Yamaguchi
    Shinji Kaneda
    Koji Kawaguchi
    Akira Shimamoto
    Makiko Kubooka
    Yoshihito Nomoto
    Motoshi Takao
    World Journal of Surgical Oncology, 19
  • [4] Endobronchial brachytherapy as definitive treatment for endobronchial metastasis after surgery of non-small cell lung cancer
    Ito, Atsushi
    Yamaguchi, Daisuke
    Kaneda, Shinji
    Kawaguchi, Koji
    Shimamoto, Akira
    Kubooka, Makiko
    Nomoto, Yoshihito
    Takao, Motoshi
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [5] Phase I trial of nedaplatin and paclitaxel for patients with non-small cell lung cancer
    Yoshiike, F
    Koizumi, T
    Kitaguchi, Y
    Hatayama, O
    Yasuo, M
    Sasabayashi, M
    Wakamatsu, H
    Fujimoto, K
    Kubo, K
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (05) : 550 - 554
  • [6] Phase II Clinical Trial of Genexol® (Paclitaxel) and Carboplatin for Patients with Advanced Non-small Cell Lung Cancer
    Kim, Han Jo
    Kim, Kyoung Ha
    Yun, Jina
    Kim, Se Hyung
    Kim, Hyun Jung
    Lee, Sang-Cheol
    Bae, Sang Byung
    Kim, Chan Kyu
    Lee, Nam Su
    Lee, Kyu Taek
    Kim, Do-Jin
    Park, Seong-Kyu
    Won, Jong-Ho
    Hong, Dae Sik
    Park, Hee Sook
    CANCER RESEARCH AND TREATMENT, 2011, 43 (01): : 19 - 23
  • [7] Paclitaxel for non-small cell lung cancer
    Ramalingam, S
    Belani, CP
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (08) : 1771 - 1780
  • [8] Pilot study of vinorelbine (Navelbine) and paclitaxel in patients with refractory non-small cell lung cancer
    Chang, AY
    DeVore, R
    Johnson, D
    SEMINARS IN ONCOLOGY, 1996, 23 (02) : 19 - 21
  • [9] Endobronchial Brachytherapy as Curative Therapy for Postoperative Intrabronchial Oligometastasis in Non-Small Cell Lung Cancer
    Ito, A.
    Kaneda, S.
    Kawaguchi, K.
    Shimamoto, A.
    Kubooka, M.
    Nomoto, Y.
    Takao, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S359 - S359
  • [10] Paclitaxel and cisplatin in patients with non-small cell lung cancer: Results of a phase II trial
    vonPawel, J
    Wagner, H
    Niederle, N
    Heider, A
    Koschel, G
    Gromotka, E
    Hanske, M
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 7 - 9
12345